The Discounted Cash Flow (DCF) valuation of Kolinpharma SpA (KIP.MI) is 8.38 EUR. With the latest stock price at 9.90 EUR, the upside of Kolinpharma SpA based on DCF is -15.4%.
Based on the latest price of 9.90 EUR and our DCF valuation, Kolinpharma SpA (KIP.MI) is a sell. selling KIP.MI stocks now will result in a potential gain of 15.4%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 6.7% | 6.0% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 4.82 - 25.35 | 8.38 |
| Upside | -51.3% - 156.0% | -15.4% |